Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Clinical Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. SPY
6. MU
7. KBH
8. HTZ
9. HON
10. JPM

Go back to Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Clinical Update

Lexicon Pharma (LXRX) Tops Q4 EPS by 24c

March 10, 2021 4:13 PM EST

Lexicon Pharma (NASDAQ: LXRX) reported Q4 EPS of ($0.04), $0.24 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $110 thousand.

For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.

... More